Rsm Us Wealth Management »

Biomarin Pharmaceutical shares owned by Rsm Us Wealth Management

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by Rsm Us Wealth Management from 13F filings

Historical chart of Rsm Us Wealth Management investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by Rsm Us Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by Rsm Us Wealth Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $23k 25k 0.93
2024-09-30 $24k 25k 0.95
2024-06-30 $24k 25k 0.96

More positions owned by Rsm Us Wealth Management

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation (NVDA)
Bank of America Corporation (BAC)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Rsm Us Wealth Management

Top funds holding Biomarin Pharmaceutical

Ing Investment Management
MacKay Shields
Wellesley Investment Advisors
Lazard Asset Management
Two Sigma Investments
Victory Capital Management
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Opti Capital Management
State Street Corporation
Morgan Stanley
Franklin Resources
Jpmorgan Chase & Co
LMR Partners

View all funds holding Biomarin Pharmaceutical